Literature DB >> 8800823

A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients.

J P Raftery1, J M Addington-Hall, L D MacDonald, H R Anderson, J M Bland, J Chamberlain, P Freeling.   

Abstract

The objective of this paper is to compare the cost effectiveness of a co-ordination service with standard services for terminally ill cancer patients with a prognosis of less than one year. We designed a randomized controlled trial, with patients randomized by the general practice with which they were registered. Co-ordination group patients received the assistance of two nurse coordinators whose role was to ensure that patients had access to appropriate services. The setting was in a South London health authority. Complete service use and outcome data were collected on 167 patients, 86 in the co-ordination group, and 81 in the control group. Our results, as previously reported, show that no differences in outcomes were detected between the co-ordination and control groups; the mean total costs incurred by the co-ordination group were significantly less than those of the control group. The co-ordinated group used significantly fewer inpatient days (mean 24 versus 40 inpatient days; t = 2.4, p = 0.002) and nurse home visits (mean 14.5 versus 37.5 visits; t = 0.3, p = 0.01). Mean cost per co-ordinated patient was almost half that of the control group patients 4774 pounds versus 8034 pounds, t = 2.8, p = 0.006). Although the unit cost data were relatively crude, these cost reductions were insensitive to a wide range of unit costs. These differences persisted when, in order to control for any putative differences in severity between the two groups, the analysis was restricted to patients who had died by the end of the study. The ratio of potential cost savings to the cost of co-ordination service was between 4:1 and 8:1. In conclusion, the co-ordination service for cancer patients who were terminally ill with a prognosis of less than one year was more cost effective than standard services, due to achieving the same outcomes at lower service use, particularly inpatient days in acute hospital. Assuming that the observed effects are real, improved co-ordination of palliative care offers the potential for considerable savings. Further research is needed to explore this issue.

Entities:  

Mesh:

Year:  1996        PMID: 8800823     DOI: 10.1177/026921639601000210

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  16 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  Specialist liaison nurses.

Authors:  R Hobbs; E T Murray
Journal:  BMJ       Date:  1999-03-13

Review 3.  Management of lung cancer.

Authors:  A Melville; A Eastwood
Journal:  Qual Health Care       Date:  1998-09

Review 4.  Living with and dying from heart failure: the role of palliative care.

Authors:  J S R Gibbs; A S M McCoy; L M E Gibbs; A E Rogers; J M Addington-Hall
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 5.  Aggressive non-Hodgkin's lymphoma: economics of high-dose therapy.

Authors:  Stephen M Beard; Lucy Wall; Louise Gaffney; Fiona Sampson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Predictors of home care expenditures and death at home for cancer patients in an integrated comprehensive palliative home care pilot program.

Authors:  Doris M Howell; Tom Abernathy; Rhonda Cockerill; Kevin Brazil; Frank Wagner; Larry Librach
Journal:  Healthc Policy       Date:  2011-02

7.  Determinants of treatment intensity for patients with serious illness: a new conceptual framework.

Authors:  Amy S Kelley; R Sean Morrison; Neil S Wenger; Susan L Ettner; Catherine A Sarkisian
Journal:  J Palliat Med       Date:  2010-07       Impact factor: 2.947

8.  Factors Associated with End-of-Life Health Service Use in Patients Dying of Cancer.

Authors:  Lisa Barbera; Jonathan Sussman; Raymond Viola; Amna Husain; Doris Howell; S Lawrence Librach; Hugh Walker; Rinku Sutradhar; Carole Chartier; Lawrence Paszat
Journal:  Healthc Policy       Date:  2010-02

9.  Does hospital at home for palliative care facilitate death at home? Randomised controlled trial.

Authors:  G E Grande; C J Todd; S I Barclay; M C Farquhar
Journal:  BMJ       Date:  1999-12-04

Review 10.  Palliative care reduces morbidity and mortality in cancer.

Authors:  Gabrielle B Rocque; James F Cleary
Journal:  Nat Rev Clin Oncol       Date:  2012-12-18       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.